top of page
istockphoto-1159531985-612x612.jpg

Video Interviews

Chronic Inflammation and its treatment with Dr. Bruce Patterson 5/21/23
27:54

Chronic Inflammation and its treatment with Dr. Bruce Patterson 5/21/23

The Lyme pandemic exposed by Covid is a compelling topic for medical care providers as long haulers continue to grow. Bruce Patterson of Incelldx joined us to present new data on Lyme and the use of Long Hauler Index (LHI) and Severity Score (SS) to diagnose and monitor Long COVID. Most importantly, this combination of algorithms has allowed the diagnosis of Chronic Lyme disease. In this video, he describes the Lyme pandemic that covid uncovered, and how they are using machine learning to understand better what patients are going through. New algorithms were discussed in his presentation with easy interpretation of the IncellKINE 14-plex cytokine panel for use by all physicians. A new report format will be shown that gives the probability of LC, Lyme, ME-CFS, or acute COVID during the initial visit to the Chronic COVID Treatment Center (CCTC). He also announced that all CCTC tests can be ordered by ANY practitioner now including MD, DO, NP, and PA. You can find him at www.covidlonghaulers.com. Kristina has been on Dr. Patterson's protocol and has seen great success in lowering multiple elevated markers! We are very grateful for doctors like Dr. Patterson that conducts research without subjective bias, to truly put patients' well being first. He will be conducting a clinical trial for the Lyme community and look forward to sharing his updates as it comes out. You will need a doctor to prescribe your protocol recommended by Dr. Patterson. His office will help you find one if you need it, direct any questions to his nurses and office that you may have. Texas Lyme Alliance, Kristina Bauer or any of our associates do not recommend using this video as medical advice. You can send this video to your doctor so they can learn about this application. Thank you Dr. Patterson, incellDX, and all our sponsors for supporting our "Chronic Inflammation Event May 2023 event". If you found this helpful, subscribe to this channel, like this video and support our work by sharing it with your healthcare practitioners, health groups, show in your support groups, and with your family. Thank you for watching and good luck! #Lyme #covid19 #Lymeresearch #nopatientleftbehind
Dr. Neil Spectors research; HS-291 therapy kills Lyme in lab + possible new Lyme diagnostic
30:48

Dr. Neil Spectors research; HS-291 therapy kills Lyme in lab + possible new Lyme diagnostic

With 477,000 newly infected Lyme patients every year, and 40% of those are pediatric, Lyme patients need a working diagnostic and effective treatment. New developments out of Duke University, carried forward from the late Oncologist and Lyme patient, Dr. Neil Spector, shows promise to solve every Lyme patients nightmare for accurate testing and an effective treatment. Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases. PORTOLA VALLEY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the development of a potential new drug, HS-291, that targets and destroys Borrelia burgdorferi, the bacterium that causes Lyme disease. Published in the peer-reviewed journal Cell Chemical Biology, this laboratory study represents a novel paradigm shift for anti-microbial treatment research as it is the first to target and inhibit Borrelia burgdorferi HtpG (high temperature protein G), a specific type of enzyme within the bacteria that causes Lyme disease— a condition affecting nearly 500,000 new patients annually. The research was conducted at Duke University School of Medicine, with collaboration from University of North Carolina, Tulane University, and Stanford University, and HS-291 is currently in preclinical stage testing at UC Davis. “As Lyme disease is currently treated with broad spectrum antibiotics and there are no targeted treatments, we are particularly excited about this discovery, and hopeful that our novel Lyme disease therapeutic HS-291 will specifically destroy the Lyme bacterium without off-target effects or antibiotic resistance,” said Timothy Haystead, PhD, professor of Pharmacology and Cancer Biology, Duke University School of Medicine, Bay Area Lyme Foundation grantee, and co-lead author. “This research has been an incredible opportunity to leverage knowledge from oncology to Lyme disease in order to design an investigational therapeutic that could one day benefit hundreds of thousands of patients with Lyme.” This new discovery has implications beyond Lyme disease as it demonstrates that using the drug HS-291 to deliver cellular toxins to HtpG, a type of non-essential enzyme that assists the folding or unfolding of large and complex proteins, greatly expands what can be considered druggable within any pathogen and opens a whole new area of infectious disease research. This work will require around a $10mm total investment to bring to the public. We are bringing this presentation to you today from Dr. Tim Haystead to show you the power of this work and why it's important to join us to support ensuring Dr Spector's mission is successful through donations. Every amount helps, so please donate at www.TXLymeAlliance.org/donate and subscribe to our channel to support our efforts to open access to care for Lyme patients. SHARE this to help us find solutions for those suffering from Lyme disease. #LymeDisease #Dukeuniversity #NeilSpector #Lymetreatment #Lymeresearch
Neuro-optometric solutions for Tick-borne illness, with Dr. Bill Padula 12/21
40:31

Neuro-optometric solutions for Tick-borne illness, with Dr. Bill Padula 12/21

This interview discusses challenges from neurological changes that can affect vision. Visual symptoms are common with tick-borne disease, and also can be associated with head concussions. Symptoms can include: blur, visual fatigue, diplopia (double vision), headaches associated with visual activities, photophobia (light sensitivity), losing place when reading, seeing words appear to double or become double when reading, and more obscure problems often not associated with vision such as difficulty with balance, spatial orientation, memory, comprehension, feeling of being over-whelmed by being in a busy-crowded environment with movement of people and objects, sensitivity to sound, to name a few. The cause of the visual symptoms is due to the tick-borne diseases affects on visual processing in the brain. The visual processing dysfunction will affect function, performance, cognitive and balance related activity. Dr. Padula discusses that 30/35 patients tested positive based on Tick/borne biomarkers he discovered in patients eyes, then confirmed these findings in blood tests. His work is pioneering, and continues to evolve. Listen to learn tips for protecting the visual and auditory process. Disulfiram has become a popular treatment and Dr. Padula discusses it's potential impact on brain processing. Compensation can create habits and coping skills that will need to be corrected through resetting and rehabilitation of the visual process. To reach Dr. Padula's office, email or call wpadula@padulainstitute.com, 800-591-1160. Physicians can take his training workshops and learn more about the impacts of tick-borne illness at https://padulainstitute.com/lyme-disease-and-vision-problems/. Other challenges are discussed using this website, and you can email any questions to them using their website. Thank you for your joining us here and hope you find this information valuable. Share it in your groups, with your family and friends, and especially with your doctors. Please check out our website at https://www.TXLymeAlliance.org for other interviews and our podcasts with top doctors in the field. And please subscribe to our channel and like this post if you find it helpful! Be well!
VMG rough cut2
03:21
Yoga4Lyme: Breathing and meditation class trailer
04:17

Yoga4Lyme: Breathing and meditation class trailer

1st class of a 3 part series for the Lyme community. The vagus nerve is essential for keeping your immune system in-check. There is a close connection between chronic stress, immune functioning, and inflammation. In brief, short-term activation of your sympathetic nervous system releases cortisol and helps keep your immune system at healthy levels. Long-term stress suppresses immunity. Activation of the vagus nerve keeps your immune system in check and releases an assortment of hormones and enzymes such as acetylcholine and oxytocin. This results in reductions in inflammation, improvement in cognition, and feelings of relaxation. We will go over two kinds of breathwork, or pranayama to stimulate the vagus nerve and help build up the immune system. Then we will relax into a peaceful meditative state. All proceeds will go to Lyme disease research! T Click this link for the full video: https://vimeo.com/ondemand/yogaforlyme. Instructions Get in a quiet, comfortable place that you will not be bothered. Turn phones and electronic devices off and get ready to relax. Make sure you are sitting in a safe area in case you fall asleep. Follow along in an easy seated position. By practicing with me, you take all liability and understand nothing discussed is medical advice. Resources: Yogic breathing when compared to attention control reduces the levels of pro-inflammatory biomarkers in saliva: a pilot randomized controlled trial, bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-016-1286-7. New Study Finds Yoga Breathing Lowers Inflammation, psychologytoday.com/us/blog/urban-survival/201610/new-study-finds-yoga-breathing-lowers-inflammation. Every Breath You Take…, drthadgala.com/every-breath-you-take/.

Kristina testified in Austin at the Texas state capitol to the Sunset Commission in 2016

 My testimony December 9th, 2016 before the Texas Sunset Advisory Commision reviewing the Texas Medical Board asking for help for Texas families for Lyme disease. 
https://tlcsenate.granicus.com/MediaPlayer.php?view_id=40&clip_id=11499​

15439711-10209278497297991-2912396377636221692-n_orig (1).jpg
kb-at-cdc-rally_orig.jpg
kb-at-cdc-rally_orig.jpg

Congenital Lyme Advocacy at the CDC Rally 2018

WhatsApp Image 2021-10-15 at 8.15.51 AM.jpeg
WhatsApp Image 2021-10-15 at 8.15.52 AM.jpeg

2016 Texas Lyme Vigil

bottom of page